Iterum Therapeutics Plc (ITRM) Tops Q1 EPS by 5c

Iterum Therapeutics Plc (NASDAQ: ITRM) reported Q1 EPS of ($0.10), $0.05 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Iterum Therapeutics Plc (ITRM) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Gauzy wins court approval for debt restructuring, SPD film output to resume
• 10 DAYS LEFT: Rackspace Technology (RXT) Investors Should Contact Block & Leviton LLP Before September 28